1643 lines (1642 with data), 406.3 kB

{"timestamp": "2025-02-20T07:42:13.863527", "level": "INFO", "name": "__main__", "module": "213583333", "function": "load_data", "line": 12, "message": "Loading data from ../data/trials.csv", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:42:13.907045", "level": "INFO", "name": "__main__", "module": "213583333", "function": "load_data", "line": 14, "message": "Successfully loaded 1759 records", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.607546", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "plot_class_distribution", "line": 126, "message": "Plot saved to figures/class_distribution.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.607892", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 130, "message": "\n=== Class Distribution Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.608113", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 131, "message": "Total number of samples: 1759", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.608644", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 132, "message": "Number of classes: 5", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.609102", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 133, "message": "\nClass distribution:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.609750", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 135, "message": "- ALS: 368.0 samples (20.9%)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.610199", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 135, "message": "- Dementia: 368.0 samples (20.9%)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.610692", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 135, "message": "- Obsessive Compulsive Disorder: 358.0 samples (20.4%)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.611015", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 135, "message": "- Scoliosis: 335.0 samples (19.0%)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.611344", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 135, "message": "- Parkinson\u2019s Disease: 330.0 samples (18.8%)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.611620", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 137, "message": "\nLargest class: ALS (368 samples)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.611946", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 138, "message": "Smallest class: Parkinson\u2019s Disease (330 samples)", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:43:07.612364", "level": "INFO", "name": "__main__", "module": "3269879791", "function": "print_distribution_insights", "line": 139, "message": "Imbalance ratio: 1.12", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.616818", "level": "INFO", "name": "__main__", "module": "912928383", "function": "plot_missing_data", "line": 137, "message": "Plot saved to figures/missing_data_analysis.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.617476", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 141, "message": "\n=== Missing Data Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.617955", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 143, "message": "Total cells in dataset: 7036", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.618275", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 144, "message": "Missing cells: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.618578", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 145, "message": "Overall missing percentage: 0.00%", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.618858", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 153, "message": "\n=== Data Quality Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.619174", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 155, "message": "Description length stats:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.619491", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 156, "message": "- Min length: 9", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.619727", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 157, "message": "- Max length: 21765", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.620034", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 158, "message": "- Mean length: 2016.46", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.620307", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 159, "message": "- Zero length entries: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.620560", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 160, "message": "- Very short descriptions: 7", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.620917", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 163, "message": "\nPotential data quality issues:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.621303", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 164, "message": "- Invalid characters: 1506", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.621688", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 165, "message": "- Multiple spaces: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.621994", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 166, "message": "- Special characters: 252", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.622260", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 169, "message": "\nDuplicate entries:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.622523", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 170, "message": "- Exact duplicates: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T07:53:38.622762", "level": "INFO", "name": "__main__", "module": "912928383", "function": "print_data_quality_insights", "line": 171, "message": "- Description duplicates: 7", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.652931", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "plot_missing_data", "line": 140, "message": "Plot saved to figures/missing_data_analysis.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.653507", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 144, "message": "\n=== Missing Data Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.653734", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 146, "message": "Total cells in dataset: 7036", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.654150", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 147, "message": "Missing cells: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.654516", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 148, "message": "Overall missing percentage: 0.00%", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.654757", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 156, "message": "\n=== Data Quality Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.655018", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 158, "message": "Description length stats:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.655325", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 159, "message": "- Min length: 9", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.655751", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 160, "message": "- Max length: 21765", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.656171", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 161, "message": "- Mean length: 2016.46", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.656482", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 162, "message": "- Zero length entries: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.656806", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 163, "message": "- Very short descriptions: 7", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.657152", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 166, "message": "\nPotential data quality issues:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.657414", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 167, "message": "- Invalid characters: 1506", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.657682", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 168, "message": "- Multiple spaces: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.657997", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 169, "message": "- Special characters: 252", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.658256", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 172, "message": "\nDuplicate entries:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.658578", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 173, "message": "- Exact duplicates: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:02:09.658871", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 174, "message": "- Description duplicates: 7", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.108182", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "plot_missing_data", "line": 140, "message": "Plot saved to figures/missing_data_analysis.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.108746", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 144, "message": "\n=== Missing Data Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.109138", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 146, "message": "Total cells in dataset: 7036", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.109395", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 147, "message": "Missing cells: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.109668", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 148, "message": "Overall missing percentage: 0.00%", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.109979", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 156, "message": "\n=== Data Quality Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.110408", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 158, "message": "Description length stats:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.110759", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 159, "message": "- Min length: 9", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.111440", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 160, "message": "- Max length: 21765", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.111748", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 161, "message": "- Mean length: 2016.46", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.112046", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 162, "message": "- Zero length entries: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.112374", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 163, "message": "- Very short descriptions: 7", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.112636", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 166, "message": "\nPotential data quality issues:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.112906", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 167, "message": "- Invalid characters: 1506", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.113164", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 168, "message": "- Multiple spaces: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.113410", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 169, "message": "- Special characters: 252", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.113666", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 172, "message": "\nDuplicate entries:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.113937", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 173, "message": "- Exact duplicates: 0", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:05:32.114202", "level": "INFO", "name": "__main__", "module": "1016578636", "function": "print_data_quality_insights", "line": 174, "message": "- Description duplicates: 7", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.464426", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "plot_special_characters", "line": 149, "message": "Plot saved to figures/special_characters.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.465025", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 153, "message": "\n=== Special Character Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.465297", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 156, "message": "\nOverall Statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.465584", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 157, "message": "Total special characters: 103733", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.465883", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 158, "message": "Unique special characters: 100", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.466293", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 159, "message": "Average per document: 58.97", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.466649", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 162, "message": "\nMost common special characters:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.466870", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- '.': 24534 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.467149", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- ',': 24365 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.467515", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- '|': 12728 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.467806", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- '-': 12421 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.468165", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- ')': 9479 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.468499", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- '(': 8972 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.468788", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- ':': 2783 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.469119", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- ''': 2022 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.469423", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- '/': 1734 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.469709", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 164, "message": "- ';': 1141 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.470019", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 167, "message": "\nClass-specific patterns:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.470344", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 169, "message": "\nALS:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.470607", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 170, "message": "- Average per document: 49.58", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.470792", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 171, "message": "- Most common characters:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.471023", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '.': 4436 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.471304", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ',': 4140 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.471712", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '|': 2524 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.472015", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '-': 2000 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.472282", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ')': 1736 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.472489", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 169, "message": "\nObsessive Compulsive Disorder:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.472750", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 170, "message": "- Average per document: 67.36", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.472996", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 171, "message": "- Most common characters:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.473209", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ',': 5589 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.473547", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '.': 5546 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.473874", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '-': 3358 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.474128", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '|': 2651 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.474399", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ')': 2422 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.474688", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 169, "message": "\nParkinson\u2019s Disease:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.475027", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 170, "message": "- Average per document: 52.77", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.475411", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 171, "message": "- Most common characters:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.475762", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ',': 4038 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.476159", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '.': 3910 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.476513", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '|': 2118 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.477024", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '-': 2002 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.477438", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ')': 1590 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.477900", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 169, "message": "\nDementia:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.478278", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 170, "message": "- Average per document: 70.22", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.478713", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 171, "message": "- Most common characters:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.479036", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ',': 6203 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.479457", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '.': 5997 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.479799", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '-': 3052 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.480194", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '|': 3030 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.480478", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ')': 2369 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.480768", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 169, "message": "\nScoliosis:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.481034", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 170, "message": "- Average per document: 54.08", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.481351", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 171, "message": "- Most common characters:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.481724", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '.': 4645 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.482092", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ',': 4395 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.482355", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '|': 2405 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.482598", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  '-': 2009 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.482859", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 173, "message": "  ')': 1362 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.483139", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 176, "message": "\nCommon patterns found:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.483467", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- percentage: 680 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.483828", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- decimal_numbers: 567 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.484169", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- parentheses: 8864 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.484557", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- brackets: 178 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.484962", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- fractions: 73 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.485223", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- plus_minus: 11 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.485481", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- milligrams: 655 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.485839", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- kilograms: 7 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.486150", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- milliliters: 52 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:09:58.486573", "level": "INFO", "name": "__main__", "module": "1802851634", "function": "print_special_char_insights", "line": 178, "message": "- ranges: 700 occurrences", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:08.362577", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "plot_ngram_distribution", "line": 110, "message": "Plot saved to figures/ngrams_1.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:08.740904", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "plot_ngram_distribution", "line": 110, "message": "Plot saved to figures/ngrams_2.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.158021", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "plot_ngram_distribution", "line": 110, "message": "Plot saved to figures/ngrams_3.png", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.158359", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 152, "message": "\n=== ALS N-gram Analysis ===", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.158591", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 155, "message": "\nTop 10 Unigrams:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.159254", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- als: 1506", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.159583", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- patients: 1013", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.159877", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- study: 1006", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.160229", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- disease: 542", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.160581", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- treatment: 467", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.160978", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- clinical: 370", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.161314", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- subjects: 341", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.161611", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- motor: 283", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.161962", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- months: 237", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.162138", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 157, "message": "- participants: 216", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.162322", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 160, "message": "\nTop 10 Bigrams:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.164290", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- will be: 1135", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.164618", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- of the: 678", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.164935", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- in the: 472", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.165228", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- the study: 299", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.165430", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- patients with: 255", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.165701", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- of als: 252", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.165963", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- is a: 249", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.166260", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- with als: 245", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.166552", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- to the: 226", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.166804", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 162, "message": "- als patients: 220", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.167023", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 165, "message": "\nTop 10 Trigrams:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.169811", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- amyotrophic lateral sclerosis: 190", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.170130", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- lateral sclerosis als: 129", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.170410", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- patients with als: 114", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.170643", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- in patients with: 91", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.170891", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- of the study: 87", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.171297", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- quality of life: 81", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.171605", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- will be performed: 79", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.171913", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- patients will be: 77", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.172182", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- subjects will be: 66", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.172432", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 167, "message": "- in als patients: 64", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.172624", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 170, "message": "\nMost Distinctive N-grams:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T08:22:09.173045", "level": "INFO", "name": "__main__", "module": "3598340874", "function": "print_ngram_insights", "line": 172, "message": "\nTop 5 distinctive 1-grams:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:14:26.396451", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.397569", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.398344", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.399080", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.399717", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.400472", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.401112", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.402359", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.402802", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:14:26.403188", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: 'ProcessingResult' object has no attribute 'split'", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.204135", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.204745", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.205292", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.205624", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.205905", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.206342", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.206816", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.207884", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.208159", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:27:41.208480", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: 'ProcessingResult' object has no attribute 'split'", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.276256", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.276922", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.277289", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.277579", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.277971", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.278418", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.278760", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.279983", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.280387", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:47:01.280762", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: object of type 'ProcessingResult' has no len()", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.466450", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.467029", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.467559", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.467990", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.468551", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.468904", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.469225", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.469950", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.470289", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:50:05.470778", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": "Task-2"}
{"timestamp": "2025-02-20T14:53:10.477269", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.477845", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.478245", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.478657", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.479176", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.479621", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.480274", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.481362", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.481806", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:53:10.482326", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.377788", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.378338", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.378785", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.379249", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.379592", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.379947", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.380249", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.380901", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.381245", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:55:17.382143", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: 'ProcessingResult' object is not subscriptable", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.805744", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.806298", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.806592", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.806913", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.807375", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.807779", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.808222", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.809087", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.809464", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:58:20.810069", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.718966", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.719407", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.719963", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.720348", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.720710", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.721184", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.721528", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.722047", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.722396", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T14:59:30.723115", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.097543", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.098150", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.098680", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.099096", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.099474", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.099791", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.100162", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.100935", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.101255", "level": "INFO", "name": "__main__", "module": "184979824", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:00:29.101822", "level": "ERROR", "name": "__main__", "module": "184979824", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": "Task-4"}
{"timestamp": "2025-02-20T15:51:58.871403", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: length_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.871643", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: whitespace_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.871804", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: special_character_cleaner", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.871952", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_score_processor", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.872152", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.872301", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_term_standardizer", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.872417", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: als_preprocessor", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.875023", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.875197", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_tokenizer", "taskName": null}
{"timestamp": "2025-02-20T15:51:58.875727", "level": "ERROR", "name": "__main__", "module": "Preprocessing", "function": "process", "line": 269, "message": "Error in preprocessing pipeline: 'ProcessingResult' object is not subscriptable", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.482302", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: length_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.482978", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: whitespace_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.483138", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: special_character_cleaner", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.483275", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_score_processor", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.483460", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.483576", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_term_standardizer", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.483691", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: als_preprocessor", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.484245", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.484379", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_tokenizer", "taskName": null}
{"timestamp": "2025-02-20T15:53:01.484905", "level": "ERROR", "name": "__main__", "module": "Preprocessing", "function": "process", "line": 269, "message": "Error in preprocessing pipeline: 'ProcessingResult' object is not subscriptable", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.090918", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: length_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.091347", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: whitespace_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.091521", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: special_character_cleaner", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.091671", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_score_processor", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.091855", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.091973", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_term_standardizer", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.092091", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: als_preprocessor", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.092646", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.092763", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_tokenizer", "taskName": null}
{"timestamp": "2025-02-20T15:58:30.093322", "level": "ERROR", "name": "__main__", "module": "Preprocessing", "function": "process", "line": 269, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.195400", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: length_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.195951", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: whitespace_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.196105", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: special_character_cleaner", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.196238", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_score_processor", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.196432", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.196550", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_term_standardizer", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.196668", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: als_preprocessor", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.197218", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.197352", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 219, "message": "Added preprocessing step: medical_tokenizer", "taskName": null}
{"timestamp": "2025-02-20T16:01:43.198343", "level": "ERROR", "name": "__main__", "module": "Preprocessing", "function": "process", "line": 269, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.579470", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: length_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.579831", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: whitespace_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.579971", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: special_character_cleaner", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.580087", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_score_processor", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.580250", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.580361", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_term_standardizer", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.580470", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: als_preprocessor", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.580989", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.581112", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_tokenizer", "taskName": null}
{"timestamp": "2025-02-20T16:09:38.582360", "level": "ERROR", "name": "__main__", "module": "Preprocessing", "function": "process", "line": 275, "message": "Error in preprocessing pipeline: expected string or bytes-like object, got 'ProcessingResult'", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.842767", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: length_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.843099", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: whitespace_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.843235", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: special_character_cleaner", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.843359", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_score_processor", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.843534", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.843651", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_term_standardizer", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.843760", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: als_preprocessor", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.844270", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": null}
{"timestamp": "2025-02-20T16:10:39.844388", "level": "INFO", "name": "__main__", "module": "Preprocessing", "function": "add_step", "line": 225, "message": "Added preprocessing step: medical_tokenizer", "taskName": null}
{"timestamp": "2025-02-20T16:24:19.827958", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.828522", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.829002", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.829532", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.829971", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.830395", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.830854", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.832033", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T16:24:19.832458", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.042996", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.043618", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.044104", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.044470", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.044729", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.045055", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.045342", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.045954", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.046254", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.046639", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 21, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.046961", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 22, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.047523", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.047785", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.048053", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.048305", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.048502", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.048795", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.049012", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.049350", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.049717", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.050417", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100mg100mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.050947", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.051184", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 205 -> 201", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.051488", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 38, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.051732", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 40, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.052028", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.052285", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100mg100mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.052635", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.052945", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 201 -> 201", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.053451", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.053873", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.054219", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.054495", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 201 -> 203", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.054806", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.055166", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.055360", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.055849", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 203 -> 203", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.056134", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.056594", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.056943", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.057317", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 203 -> 203", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.057630", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 38, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.057970", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.058360", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.058552", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.058798", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 203 -> 165", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.059014", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 38, "message": "- Medical terms: ['ALS', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.059323", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.059685", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65%\u00b15%.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.060042", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.060309", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 218 -> 165", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:00:55.060791", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.348492", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.349296", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.350571", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.351147", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.351739", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.352345", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.352765", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.353705", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.354487", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.354969", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 21, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.355510", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 22, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.355980", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.356283", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.356626", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.356844", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.357102", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.357377", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.357696", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.357942", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.358253", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.358960", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.359168", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.359475", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.359798", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 38, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.360059", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 40, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.360399", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.360651", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.360861", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.361160", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.361486", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.361960", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.362305", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.362689", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.362974", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.363342", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.363541", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.363849", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.364161", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.364463", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.364761", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.365076", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.365401", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 38, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.365778", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.366228", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.366529", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.366803", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.367214", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 38, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.367598", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 29, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.368270", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 31, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.368598", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 35, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.368977", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 36, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:10:06.369416", "level": "INFO", "name": "__main__", "module": "1434864822", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.974248", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.974696", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.975149", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.975529", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.975921", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.976228", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.976447", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.977115", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.977501", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:11:26.978070", "level": "ERROR", "name": "__main__", "module": "2914501069", "function": "process", "line": 63, "message": "Error in preprocessing pipeline: 'ProcessingResult' object is not subscriptable", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.344318", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.344988", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.345517", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.346099", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.346481", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.346829", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.347240", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.347869", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.348247", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.348755", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.349170", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.349680", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.349969", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.350323", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.350688", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.351191", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.351565", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.351916", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.352246", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.352593", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.353105", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.353312", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.353536", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.353870", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.354265", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.354542", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.354758", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.355037", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.355227", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.355481", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.355725", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.356049", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.356367", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.356680", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.357161", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.357519", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.357882", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.358430", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.358740", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.359158", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.359453", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.359820", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.360231", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.360705", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.361116", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.361537", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.361810", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.361998", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.362241", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.362617", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.362924", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:12:46.363358", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.176449", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.177374", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.178373", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.179058", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.179675", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.180196", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.180602", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:18:49.181291", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.929968", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.930598", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.931098", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.931493", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.931704", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.931887", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.932339", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:19:12.933119", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.776816", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.777271", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.777793", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.778153", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.778589", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.779006", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.779413", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.780235", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.781058", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.781360", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.781807", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.782205", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.782737", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.783073", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.783441", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.783786", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.784109", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.784475", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.784820", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.785231", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.785557", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.786046", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.786805", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.787341", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.787816", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.788179", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.788436", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.788853", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.789154", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.789407", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.789742", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.790300", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.790685", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.791029", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.791315", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.791820", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.792189", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.792476", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.792925", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.793491", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.793958", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.794939", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.795212", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.795484", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.795905", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.796079", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.796272", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.796539", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.796875", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.797646", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After improved_medical_preprocessor: ALS( amyotrophic lateral sclerosis) showing respiratory decline FVC3 months \u00b1 100 mg. ALSscore decreased 42 38 3 months. received treatment with100 mg3 monthsmedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.797991", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.798263", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 169 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.798629", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', 'FVC', '3 months', '100 mg']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.798992", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.799304", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS( amyotrophic lateral sclerosis) showing respiratory decline FVC3 months \u00b1 100 mg. ALS score decreased 42 38 3 months. received treatment with100 mg3 monthsmedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.799594", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.799867", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 170 -> 170", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:23:27.800124", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.057533", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.057884", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.058202", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.058665", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.059081", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.059477", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.059935", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.060882", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.061205", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.061578", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.062047", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.062474", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.062938", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.063312", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.063655", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.063992", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.064345", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.064694", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.065047", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.065358", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.065635", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.066086", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.066423", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.066803", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.067179", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.067520", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.067863", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.068134", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.068365", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.068803", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.069185", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.069542", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.069926", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.070414", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.070671", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.071138", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.071386", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.071651", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.072058", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.072393", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.072675", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.072856", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.073190", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.073573", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.073989", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.074378", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.074737", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.075112", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.075434", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.076222", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After improved_medical_preprocessor: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 100 mg/day. ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.076532", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.076964", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 169 -> 176", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.077341", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 39, "message": "- Medical terms: ['FVC65 %', '100 mg/day', '5 %', 'ALS', 'ALS', '(amyotrophic lateral sclerosis)']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.077704", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.078066", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 100 mg/day. ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.078454", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.078662", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 37, "message": "- Length change: 178 -> 178", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:26:06.078954", "level": "INFO", "name": "__main__", "module": "2923849447", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.280218", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.280765", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.298016", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.298524", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.298956", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.299384", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.299775", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.300739", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.300997", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.301373", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.301748", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.302102", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.302570", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.302960", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.303326", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.303858", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.304224", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.304596", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.304876", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.305123", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.305420", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.305913", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.306134", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.306382", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.306647", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.307171", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.307502", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.307823", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.308220", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.308559", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.308832", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.309143", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.309473", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.309668", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.309975", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.310405", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.310725", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.311022", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.311294", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.311705", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.312004", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.312350", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.312792", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.313071", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.313500", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.313797", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.314027", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.314269", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.314598", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.315204", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After improved_medical_preprocessor: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 100 mg/day. ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.315466", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.315764", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 169 -> 176", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.316143", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['FVC65 %', '100 mg/day', '5 %', 'ALS', 'ALS', '(amyotrophic lateral sclerosis)']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.316536", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.316910", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 100 mg/day. ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.317262", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.317583", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 178 -> 178", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:27:44.317866", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.154712", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.155294", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.155752", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.156065", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.156563", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.156966", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.157314", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.157908", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.158208", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.158510", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.159056", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.159437", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.159851", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.160207", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.160539", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.160893", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.161244", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.161573", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.161942", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.162264", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.162564", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.163093", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.163401", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.163707", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.163969", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.164258", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.164528", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.164898", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.165211", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.165519", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.165812", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.166178", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.166357", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.166520", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.166812", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.167446", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.167885", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.168261", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.168591", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.168848", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.169040", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.169230", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.169466", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.169717", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.170064", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.170313", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.170539", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.170795", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.171021", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.171323", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.171504", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.171657", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.172104", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 30, "message": "\nApplying improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.172465", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 32, "message": "After improved_medical_preprocessor: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 100 mg/day. ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.172734", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.173036", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 178", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.173552", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 39, "message": "- Medical terms: ['FVC65 %', '100 mg/day', '5 %', 'ALS', 'ALS', '(amyotrophic lateral sclerosis)']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:30:49.173934", "level": "INFO", "name": "__main__", "module": "3073145723", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.039874", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.040366", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.040753", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.041171", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.041653", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.042093", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.042487", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.043137", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.043563", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.044065", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.044456", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.044847", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.045308", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.045622", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.045918", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.046272", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.046624", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.047087", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.047458", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.047769", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.048120", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.048694", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.048964", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.049361", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.049737", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.050041", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.050367", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.050728", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.051112", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.051538", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.051857", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.052333", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.052794", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.053133", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.053327", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.053777", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.053966", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.054371", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.054632", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.055079", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.055295", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.055562", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.055779", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.055999", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.056504", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.056809", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.057011", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.057273", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.057532", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.057842", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.058169", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.058497", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.058770", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 30, "message": "\nApplying improved_medical_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.059133", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 32, "message": "After improved_medical_preprocessor: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 100 mg/day. ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.059429", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.059759", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 178", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.060118", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 39, "message": "- Medical terms: ['FVC65 %', '100 mg/day', '5 %', 'ALS', 'ALS', '(amyotrophic lateral sclerosis)']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:31:52.060549", "level": "INFO", "name": "__main__", "module": "2433205494", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.120003", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.120304", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.120937", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.121196", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.121515", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.121906", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.122218", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.122747", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.123077", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.123655", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.124058", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.124573", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.124905", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.125270", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.125632", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.125930", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.126222", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.126490", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.126750", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.127043", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.127531", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.127711", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.128045", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.128281", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.128540", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.128845", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.129106", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.129526", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.129833", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.130178", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.130468", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.130850", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.131048", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.131360", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.131933", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.132202", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.132507", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.132825", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.133150", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.133503", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.133842", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.134142", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.134510", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.134909", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.135226", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.135432", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.135705", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.135955", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.136299", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.136609", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.136864", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:33:37.137187", "level": "INFO", "name": "__main__", "module": "849556997", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.831799", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.832489", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.833018", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.833404", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.833824", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.834310", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.834706", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.835636", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.835994", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.836490", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.836799", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.837244", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.837579", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.837854", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.838129", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.838525", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.838980", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.839440", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.839937", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.840269", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.840935", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.841275", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.841599", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.841999", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.842491", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.842892", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.843259", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.843527", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.843978", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.844388", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.844919", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.845261", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.845576", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.845792", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.846234", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.846484", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.846853", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.847208", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.847670", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.848138", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.848728", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.849105", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.849561", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.850054", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.850464", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.850773", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.850986", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.851176", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.851609", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.851845", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.852051", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:36:50.852416", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.784776", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.785445", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.786061", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.786642", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.787225", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.788016", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.788758", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.791607", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.792323", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.792906", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.793350", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.793865", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.794497", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.794833", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.795204", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.795723", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.796177", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.796735", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.797249", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.797703", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.798444", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.798862", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.799216", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.799562", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.799956", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.800362", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.801062", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.801466", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.801828", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.802231", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.802777", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.803127", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.803481", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.803818", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.804699", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.805071", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.805793", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.806787", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.807465", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.807979", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.808507", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.809021", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.809456", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.811344", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.811865", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.812602", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.812970", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.813452", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.814090", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.814609", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.814906", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:40:31.815267", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.154551", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.155175", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.155822", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.156589", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.157001", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.157674", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.158043", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.158821", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.159111", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.159515", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.159822", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.160253", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.160520", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.160856", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.161194", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.161533", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.161834", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.162087", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.162452", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.162688", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.163221", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.163551", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.163988", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.164289", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.164807", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.165183", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.165644", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.166096", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.166398", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.166854", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.167323", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.167566", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.168085", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.168518", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.169171", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.169530", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.170126", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.170529", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.170965", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.171339", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.171660", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.171959", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.172282", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.172701", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.173110", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.173563", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.173959", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.174304", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.174803", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.175221", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.175454", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T17:44:45.175992", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T21:43:19.176002", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.178146", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.178676", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.179220", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.179722", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.180193", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.180788", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.182869", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.183353", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.183847", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.184205", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.184605", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.184845", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.185105", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.185454", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.185755", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.186083", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.186428", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.186740", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.187009", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.187967", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.188384", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.188730", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.188997", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.189308", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {';': 1, '=': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.189633", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.190470", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.190710", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.190984", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.191289", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.192004", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.192245", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.192651", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.192933", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.194119", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.194386", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.194572", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.194755", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.195175", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.195429", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.195639", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.195932", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.196149", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.196840", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.197213", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.197492", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.197676", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.198045", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.198717", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.199088", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.199522", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-4"}
{"timestamp": "2025-02-20T21:43:19.199819", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.782305", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.783352", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.783813", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.784197", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.784844", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.785358", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.785699", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.786481", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.786882", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.787549", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.788117", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.788684", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.788962", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.789226", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.789525", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.789779", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.790177", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.790489", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.790830", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.791140", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.791771", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.792167", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.792468", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.792839", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.793213", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'[': 32, '{': 32, '+': 32, ';': 32, '_': 32, '=': 32, '*': 32, '\\\\': 32, ':': 32, '}': 32, ']': 32, '|': 32, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.794043", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.794372", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.794624", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.795064", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.795390", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.796001", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.796446", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.796967", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.797292", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.797778", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.798093", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.798440", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.798850", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.799581", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.799995", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.800499", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.801041", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.801678", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.802276", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.802585", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.802915", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.803143", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.803465", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.803922", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.804191", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.804513", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:05:47.804905", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:18:47.934024", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.934616", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.935005", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.935481", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.935854", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.936226", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.936656", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.937983", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.938466", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.938767", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.939062", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.939453", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.939702", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.939935", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.940179", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.940444", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.940704", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.940926", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.941156", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.941380", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.942294", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.942501", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.942788", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.943081", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.943325", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.943572", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.944481", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.944739", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.945000", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.945268", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.945906", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.946126", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.946340", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.946559", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.947564", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.947802", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.948011", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.948345", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.948809", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.949092", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.949417", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.949615", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.949766", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.950375", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.950716", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.950971", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.951159", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.951350", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.951862", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.952225", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.952513", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:18:47.952804", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:25:03.798864", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.799524", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.800109", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.800645", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.801170", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.801742", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.802326", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.803666", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.804615", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.804987", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.805410", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.805900", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.806267", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.806786", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.807105", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.807393", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.807687", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.807923", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.808209", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.808479", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.809484", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.809732", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.809925", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.810149", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.810392", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'_': 0, '*': 0, '\\\\': 0, '{': 0, ';': 1, '|': 0, ':': 0, '[': 0, '}': 0, '=': 1, ']': 0, '+': 0, '(': 1, ')': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.810638", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.811402", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.811678", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.812078", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.812576", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.813404", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.813679", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.813928", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.814348", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.815534", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.815756", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.816004", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.816200", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.816678", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.816955", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.817250", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.817558", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.817827", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.818402", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.818710", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.819037", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.819438", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.819666", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.820318", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.821015", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.821536", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:25:03.822141", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.684347", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.684953", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.685537", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.685963", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.686419", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.686830", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.687226", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.688679", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.689196", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.689530", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.689827", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.690166", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.690403", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.690654", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.690991", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.691281", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.691542", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.691834", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.692085", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.692318", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.692869", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.693084", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.693353", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.693608", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.693864", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.694167", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.694929", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.695152", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.695379", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.695637", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.696237", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.696514", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.696839", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.697180", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.698590", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.698874", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.699142", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.699342", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.699730", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.700083", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.700372", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.700635", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.700831", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.701416", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.701750", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.702037", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.702287", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.702491", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.703073", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.703303", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.703619", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:30:19.703969", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:33:50.783657", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.784552", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.785011", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.785432", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.785818", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.786298", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.786810", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.788071", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.788550", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.788897", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.789170", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.789556", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.789811", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.790068", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.790304", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.790533", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.790782", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.791030", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.791295", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.791531", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.792471", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.792697", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.792935", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.793292", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.793552", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'=': 1, ';': 1, '(': 1, ')': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.793781", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.794508", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.794747", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.794971", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.795199", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.795793", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.796083", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.796343", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.796592", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.797905", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.798199", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.798418", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.798629", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.798990", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.799279", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.799432", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.799590", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.799836", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.800360", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.800628", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.800894", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.801137", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.801289", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.801860", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.802117", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.802339", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:33:50.802574", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.011504", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.012320", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.012865", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.013358", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.013780", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.014199", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.014685", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.015907", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.016550", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.016931", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.017232", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.017736", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.018030", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.018282", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.018541", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.018798", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.019111", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.019391", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.019703", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.019961", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.020952", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.021268", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.021554", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.021905", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.022255", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'|': 0, '*': 0, '{': 0, ';': 1, '=': 1, ']': 0, '}': 0, '\\\\': 0, '+': 0, '[': 0, '_': 0, ':': 0, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.022618", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.023417", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.023689", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.024007", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.024291", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.025006", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.025331", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.025683", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.025998", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.027249", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.027493", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.027788", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.028126", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.028624", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.028975", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.029248", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 207", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.029439", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.029781", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.030430", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFRS-Rscore decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.030757", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.031060", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 207 -> 169", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.031249", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '5', '42', '38', '3', 'treatment']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.031484", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.032053", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC65 % \u00b1 5 %.ALSFR S-R score decreased 42 38 3 months. received treatment with100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.032387", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.032690", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 171 -> 171", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:39:45.032939", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:50:00.803196", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.806519", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.807172", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.807742", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.808209", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.808744", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.809266", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.811161", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.811615", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.811974", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.812270", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.812740", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.813065", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.813379", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.813778", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.814199", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.814566", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.814839", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.815087", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.815319", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.816339", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.816568", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.816794", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 211", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.817035", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.817296", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'[': 0, '|': 0, '*': 0, ':': 0, '{': 0, '_': 0, ']': 0, '+': 0, ';': 1, '\\\\': 0, '=': 1, '}': 0, '(': 1, ')': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.817579", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.818432", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.818706", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.819027", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 211", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.819286", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.819948", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.820216", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.820505", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 235", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.820757", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.822058", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.822468", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.822793", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.823017", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.823480", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.823736", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.823950", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.824148", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.824384", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.824931", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.825146", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.825396", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 191", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.825626", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '65', '5', '42', '38', '3', 'treatment', '100']", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.825909", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.826478", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline F orced V ital C apacity (FVC) 65 % \u00b1 5 %. ALSFR S-R score decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.826652", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.826924", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 196 -> 196", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:50:00.827352", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-4"}
{"timestamp": "2025-02-20T22:52:32.723686", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.724503", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.725088", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.725687", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.726184", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.726738", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.727280", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.728706", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.729282", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.729715", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.730315", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.730839", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.731203", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.731548", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.731820", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.732169", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.732477", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.732840", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.733161", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.733457", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.734568", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.734933", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.735297", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 211", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.735656", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.736073", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'}': 0, ']': 0, ':': 0, '{': 0, '=': 1, '\\\\': 0, '_': 0, '+': 0, '*': 0, '[': 0, ';': 1, '|': 0, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.736407", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.737314", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.737669", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.738148", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 211", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.738666", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.739526", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.739840", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.740106", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 235", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.740389", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.741433", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.741649", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.741983", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.742303", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.742738", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.742935", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.743105", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.743334", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.743686", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.744283", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.744470", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.744676", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 191", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.744905", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '65', '5', '42', '38', '3', 'treatment', '100']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.745254", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.746412", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline F orced V ital C apacity (FVC) 65 % \u00b1 5 %. ALSFR S-R score decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.746791", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.747220", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 196 -> 196", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:52:32.747788", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T22:55:32.929223", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.929999", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.930598", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.931067", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.931531", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.931955", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.932430", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.933713", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.934296", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.934743", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.935083", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.935508", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.935773", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.936003", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.936231", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.936470", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.936704", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.936952", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.937208", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.937563", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.938606", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.938815", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.939034", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 211", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.939278", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.939524", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'|': 0, '\\\\': 0, '+': 0, ']': 0, '{': 0, '=': 1, '_': 0, '[': 0, '}': 0, '*': 0, ';': 1, ':': 0, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.939760", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.940511", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.940757", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.940993", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 211", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.941226", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.941798", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.942048", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.942275", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 235", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.942440", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.943665", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.943923", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.944243", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.944539", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.945044", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.945280", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.945434", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.945737", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.945986", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.946530", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.946751", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.947184", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 191", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.947420", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '65', '5', '42', '38', '3', 'treatment', '100']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.947641", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.948248", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline F orced V ital C apacity (FVC) 65 % \u00b1 5 %. ALSFR S-R score decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.948462", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.948712", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 196 -> 196", "taskName": "Task-2"}
{"timestamp": "2025-02-20T22:55:32.949044", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:03.454282", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.455022", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.455463", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.455904", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.456395", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.456780", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.457232", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.458520", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.459112", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.459525", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.459813", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.460265", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.460583", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.460939", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.461218", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.461492", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.461768", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.462178", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.462435", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.462705", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.463673", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.463905", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.464236", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 211", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.464571", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.464892", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'|': 0, '*': 0, '}': 0, ';': 1, '{': 0, '[': 0, '+': 0, '\\\\': 0, ':': 0, '=': 1, '_': 0, ']': 0, '(': 1, ')': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.465157", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.466011", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.466317", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.466661", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 211", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.467031", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.467735", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.468012", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.468250", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 235", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.468500", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.469540", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.469798", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.470133", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.470480", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.470947", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.471357", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.471635", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.471943", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.472384", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.472915", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.473223", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.473519", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 191", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.473729", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '65', '5', '42', '38', '3', 'treatment', '100']", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.473905", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.474481", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline F orced V ital C apacity (FVC) 65 % \u00b1 5 %. ALSFR S-R score decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.474710", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.474902", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 196 -> 196", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:03.475205", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-3"}
{"timestamp": "2025-02-20T23:00:46.897862", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.898779", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.899514", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.900084", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.900676", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.901296", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.901746", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.902895", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.903331", "level": "INFO", "name": "__main__", "module": "2914501069", "function": "add_step", "line": 13, "message": "Added preprocessing step: medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.903652", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 24, "message": "Starting text preprocessing", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.904035", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 25, "message": "Original text: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; \n               FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. \n               The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.904491", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying whitespace_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.904771", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After whitespace_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.905026", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.905301", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 237 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.905651", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying length_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.906002", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After length_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline; FVC = 65% \u00b1 5%. ALSFRS-R score decreased from 42 to 38 over 3 months. The subject received treatment with 100mg/day medication.", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.906263", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.906534", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 205", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.906864", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying special_character_cleaner", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.907984", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After special_character_cleaner: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.908320", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.908674", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 205 -> 211", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.909000", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['measurements: 65%', 'measurements: 5%', 'compound_terms: ALSFRS-R', 'measurements: 100mg', 'compound_terms: 100mg/day']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.909275", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 41, "message": "- Special chars: {'\\\\': 0, '|': 0, '}': 0, ':': 0, ';': 1, ']': 0, '*': 0, '{': 0, '+': 0, '_': 0, '[': 0, '=': 1, ')': 1, '(': 1, '\u00b1': 1, '.': 3}", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.909528", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_score_processor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.910459", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_score_processor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline FVC 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.910818", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.911157", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 211", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.911503", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_abbreviation_normalizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.912163", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_abbreviation_normalizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.912357", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.912639", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 211 -> 235", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.913028", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_term_standardizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.914246", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_term_standardizer: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.914575", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.914944", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.915342", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying als_preprocessor", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.915914", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After als_preprocessor: Patient with ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased from 42 to 38 over 3 months. The subject received treatment with 100 mg100 mg/daymedication . ", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.916360", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.916704", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 235", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.917182", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['amyotrophic lateral sclerosis', 'respiratory']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.917567", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying domain_specific_stopword_handler", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.918253", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After domain_specific_stopword_handler: ALS (amyotrophic lateral sclerosis) showing respiratory decline Forced Vital Capacity (FVC) 65 % \u00b1 5 %. ALSFRS-Rscore decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.918638", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.919014", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 235 -> 191", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.919329", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 39, "message": "- Medical terms: ['ALS', '65', '5', '42', '38', '3', 'treatment', '100']", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.919707", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 30, "message": "\nApplying medical_tokenizer", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.920254", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 32, "message": "After medical_tokenizer: ALS (amyotrophic lateral sclerosis) showing respiratory decline F orced V ital C apacity (FVC) 65 % \u00b1 5 %. ALSFR S-R score decreased 42 38 3 months. received treatment 100 mg100 mg/daymedication .", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.920663", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 36, "message": "Step statistics:", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.920888", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 37, "message": "- Length change: 196 -> 196", "taskName": "Task-2"}
{"timestamp": "2025-02-20T23:00:46.921146", "level": "INFO", "name": "__main__", "module": "2835056842", "function": "<module>", "line": 43, "message": "\nPreprocessing complete", "taskName": "Task-2"}